4Filing Date: Oct 9, 2026

Verisk Analytics (VRSK) 4: 156-share board retainer grant (Oct 9, 2026)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001193125-26-419142
Total Value$0
Trades1
Insiders1

Transaction Details

Patiath Pradip
Director·Direct
Grant · Acquire
Common Stock
Shares+156
Price$0.00
Total Value$0
Shares Owned After1.58K
Transaction DateSep 30, 2026
Footnotes ▸

The reporting person elected to receive shares of Common Stock under the Issuer's 2021 Equity Incentive Plan as part of the reporting person's annual Board member retainer fee which is paid quarterly in arrears.

Post-Transaction Holdings

Patiath Pradip · Director
SecuritySharesChange
Common Stock1.58K+156 (10.98%)
auto_awesome

Deep Analysis

Verisk director Pradip Patiath received 156 shares of common stock as his quarterly Board retainer under the 2021 Equity Incentive Plan — a compensation grant, not an open-market buy, and no shares were sold.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-30 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Verisk Analytics, Inc. (VRSK) CIK: 0001442145 --- Reporting Owner --- Name: Patiath Pradip CIK: 0002136149 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-30 | Code: A (Grant or award) Shares: +156 | Price: $0.00 Shares Owned After: 1,577 | Ownership: D (Direct) Footnotes: [F1] The reporting person elected to receive shares of Common Stock under the Issuer's 2021 Equity Incentive Plan as part of the reporting person's annual Board member retainer fee which is paid quarterly in arrears. --- Footnotes (Complete Index) --- F1: The reporting person elected to receive shares of Common Stock under the Issuer's 2021 Equity Incentive Plan as part of the reporting person's annual Board member retainer fee which is paid quarterly in arrears. --- Signature --- /s/ /s/ Kathy Card Beckles, Attorney-in-fact (2026-10-09)

keid analysis is for reference only and does not constitute investment advice.